Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation

γ-生育酚化学预防木烟PM2.5引起的气道炎症

基本信息

  • 批准号:
    9055845
  • 负责人:
  • 金额:
    $ 58.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Wood smoke particles (WSP) derived from wildland and other fires produce a significant fraction of ambient air particulate matter. Health effects associated with WSP include acute bronchitis, asthma exacerbation, pneumonia, cough and systemic inflammation in in healthy persons and those with asthma. Cardiovascular effects have also been reported with WSP exposure. WSP from wildland fires can cause abrupt increases in ambient air PM 2.5 levels, and avoidance of rapidly increasing PM air pollution is not feasible as many residents cannot leave the burn region, and wildland firefighters move into wildland fire sites, often for several consecutive days. As avoidance of PM is not feasible in these settings, there is a clear unmet need for interventions to reduce adverse health effects caused by acute WSP exposure. Our team has developed gamma tocopherol (gT), an isoform of vitamin E with robust anti-inflammatory actions, as a chemopreventive intervention for inflammation caused by environmental contaminants. Our animal studies show that gT inhibits allergen, ozone and endotoxin-induced airway inflammation. Our human phase I studies show that gT decreases inflammatory response of circulating monocytes, decreases nitrosative stress, and inhibits neutrophil (PMN) influx to the airway in vivo after endotoxin challenge. Thus, gT supplementation is an attractive nutritional/nutraceutical approach to decreasing the adverse health effects of inhaled WSP. We have also developed a 500µg/m3 WSP exposure protocol which induces both airway and systemic increases in PMNs in human volunteers. Using this challenge protocol, we will undertake a randomized, placebo-controlled study to determine if of supplementation with 1200 mg of on WSP-induced airway and systemic PMN increases in healthy and asthmatic volunteers. Exploratory endpoints will include non-specific bronchial reactivity (NSBR), and cardiovascular responses reported to be impacted by PM exposure. These studies will also allow us to compare responses of allergic asthmatic (AA) and healthy volunteers (HV) to determine if atopy or other facets of asthma modify risk for inflammatory response to WSP. This study will be the first to test a specific nutritional supplement as a chemopreventive intervention for WSP-induced inflammation in either AAs or NVs, and to specifically compare the response of these groups to WSP-induced inflammation.
 描述(由适用提供):衍生自野外和其他火灾的木烟颗粒(WSP)产生了很大一部分环境空气颗粒物。与WSP相关的健康作用包括健康人和患有哮喘患者的急性支气管炎,哮喘的出现,肺炎,咳嗽和全身性炎症。还报道了WSP暴露的心血管效应。 Wildland大火的WSP会导致周围空气PM 2.5水平的突然增加,并且避免迅速增加的PM空气污染是不可行的,因为许多居民无法离开烧伤区域,而Wildland Firefighters通常会连续几天进入Wildland Fire站点。由于在这些情况下避免PM是不可行的,因此明显未满足的干预措施可以减少急性WSP暴露造成的不良健康影响。我们的团队已经开发了伽马生育酚(GT),这是一种具有强大的抗炎作用的维生素E的同工型,作为由环境污染物引起的感染的化学预防干预措施。我们的动物研究表明,GT抑制过敏原,臭氧和内毒素诱导的气道感染。我们的人类I期研究表明,GT会降低循环单核细胞的炎症反应,减少硝化应激,并抑制内毒素挑战后体内气道对气道的影响(PMN)。这是GT补充是一种有吸引力的营养/营养方法,可降低遗传WSP的不良健康影响。我们还开发了500µg/m3 WSP暴露方案,该方案诱导了人类志愿者的PMN的气道和全身增加。使用此挑战方案,我们将进行一项随机,安慰剂对照的研究,以确定是否补充了1200 mg的WSP诱导的气道,并且健康和哮喘的志愿者的全身性PMN增加。探索性终点将包括非特异性支气管反应性(NSBR)和据报道受PM暴露影响的心血管反应。这些研究还将使我们能够比较过敏性哮喘(AA)和健康志愿者(HV)的反应,以确定特应性或其他哮喘方面是否改变了对WSP炎症反应的风险。这项研究将是第一个测试特定营养补充剂作为AAS或NVS中WSP诱导的炎症的化学预防干预措施,并专门比较这些组对WSP诱导的炎症的反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David B. Peden其他文献

Effect of prednisone on woodsmoke-induced sputum inflammation in healthy volunteers: A randomized, placebo-controlled pilot study
  • DOI:
    10.1016/j.jacig.2024.100347
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Terry L. Noah;Neil E. Alexis;William D. Bennett;Michelle L. Hernandez;Allison J. Burbank;Haolin Li;Haibo Zhou;Ilona Jaspers;David B. Peden
  • 通讯作者:
    David B. Peden
Impact of Aeroallergen Sensitization on Asthma Control in African-American Teens with Persistent Asthma
空气过敏原敏化对患有持续性哮喘的非洲裔美国青少年哮喘控制的影响
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Burbank;S. Grabich;Krista Todorich;Marcia Frye;C. Loughlin;Kelly Duncan;C. Robinette;K. Mills;David B. Peden;David Diaz;Michelle L. Hernandez
  • 通讯作者:
    Michelle L. Hernandez
Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile
  • DOI:
    10.1016/j.jaci.2011.11.007
  • 发表时间:
    2012-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michelle Hernandez;Willie June Brickey;Neil E. Alexis;Rebecca C. Fry;Julia E. Rager;Baiming Zhou;Jenny P.Y. Ting;Haibo Zhou;David B. Peden
  • 通讯作者:
    David B. Peden

David B. Peden的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David B. Peden', 18)}}的其他基金

Research Training in Allergy and Clinical Immunology
过敏和临床免疫学研究培训
  • 批准号:
    10493540
  • 财政年份:
    2022
  • 资助金额:
    $ 58.08万
  • 项目类别:
Research Training in Allergy and Clinical Immunology
过敏和临床免疫学研究培训
  • 批准号:
    10686797
  • 财政年份:
    2022
  • 资助金额:
    $ 58.08万
  • 项目类别:
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
项目 4:用新型粘液溶解剂治疗哮喘粘膜淤积和气道阻塞
  • 批准号:
    10001602
  • 财政年份:
    2017
  • 资助金额:
    $ 58.08万
  • 项目类别:
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
项目 4:用新型粘液溶解剂治疗哮喘粘膜淤积和气道阻塞
  • 批准号:
    9356821
  • 财政年份:
    2017
  • 资助金额:
    $ 58.08万
  • 项目类别:
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation
γ-生育酚化学预防木烟PM2.5引起的气道炎症
  • 批准号:
    9222012
  • 财政年份:
    2016
  • 资助金额:
    $ 58.08万
  • 项目类别:
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation
γ-生育酚化学预防木烟PM2.5引起的气道炎症
  • 批准号:
    9883794
  • 财政年份:
    2016
  • 资助金额:
    $ 58.08万
  • 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
  • 批准号:
    9269215
  • 财政年份:
    2013
  • 资助金额:
    $ 58.08万
  • 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
  • 批准号:
    8598698
  • 财政年份:
    2013
  • 资助金额:
    $ 58.08万
  • 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
  • 批准号:
    8733697
  • 财政年份:
    2013
  • 资助金额:
    $ 58.08万
  • 项目类别:
Phase II studies of gamma tocopherol as an intervention for environmental asthma
γ-生育酚作为环境性哮喘干预措施的 II 期研究
  • 批准号:
    9057036
  • 财政年份:
    2013
  • 资助金额:
    $ 58.08万
  • 项目类别:

相似国自然基金

用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
  • 批准号:
    32301097
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
  • 批准号:
    82300739
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
  • 批准号:
    32371426
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
  • 批准号:
    82302221
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
转录谱分析可区分细菌性和非细菌性呼吸道疾病
  • 批准号:
    10084258
  • 财政年份:
    2019
  • 资助金额:
    $ 58.08万
  • 项目类别:
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
转录谱分析可区分细菌性和非细菌性呼吸道疾病
  • 批准号:
    10349622
  • 财政年份:
    2019
  • 资助金额:
    $ 58.08万
  • 项目类别:
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
转录谱分析可区分细菌性和非细菌性呼吸道疾病
  • 批准号:
    10357572
  • 财政年份:
    2019
  • 资助金额:
    $ 58.08万
  • 项目类别:
Real-time Asthma and Air Pollution Project (Asthma APP)
实时哮喘与空气污染项目(哮喘APP)
  • 批准号:
    9077039
  • 财政年份:
    2015
  • 资助金额:
    $ 58.08万
  • 项目类别:
The Health and Poverty Effects of a Large-scale Cookstove Initiative in Rwanda
卢旺达大规模炉灶计划对健康和贫困的影响
  • 批准号:
    8673154
  • 财政年份:
    2014
  • 资助金额:
    $ 58.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了